Economic burden of beta-thalassemia/Hb e and beta-thalassemia major in Thai children

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Riewpaiboon, Arthorn ^a   Nuchprayoon, Issarang ^b   Torcharus, Kitti ^c   Indaratna, Kaemthong ^b   Thavorncharoensap, Montarat ^a   Ubol, Bang On ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^d Saraburi Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949493576     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-29     Document Type: Article

References (26)

1. The impact of iron overload and its treatment on quality of life: results from a literature review. L Abetz JF Baladi P Jones D Rofail, Health Qual Life Outcomes 2006 4 73 10.1186/1477-7525-4-73 17007645
2. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. V De Sanctis M Roos T Gasser M Fortini G Raiola MC Galati, J Pediatr Endocrinol Metab 2006 19 4 471 480 16759032
3. Changes in the epidemiology of thalassemia in North America: a new minority disease. EP Vichinsky EA MacKlin JS Waye F Lorey NF Olivieri, Pediatrics 2005 116 6 818 825 10.1542/peds.2005-0843 16291734
4. Diagnosis of thalassemia carrier (in Thai language). Thai Thalassemia Foundation, http://www.thalassemia.or.th/thaiversion/diag-carrier-th.htm
5. Thalassemia in Sri Lanka: a progress report. A Premawardhena S De Silva M Arambepola N Olivieri L Merson J Muraco A Allen C Fisher T Peto E Vichinsky, et al. Hum Mol Genet 2004 13 Spec No 2 203 206 10.1093/hmg/ddh250 15358726
6. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group. A Premawardhena S De Silver M Arambepola NF Olivieri EP Vichinsky L Merson G Muraco A Allen C Fisher T Peto, et al. Ann N Y Acad Sci 2005 1054 33 39 10.1196/annals.1345.005 16339649
7. Genetic factors affecting clinical severity in beta-thalassemia syndromes. P Winichagoon S Fucharoen P Chen P Wasi, J Pediatr Hematol Oncol 2000 22 6 573 580 10.1097/00043426-200011000-00026 11132233
8. Lifetime treatment costs of beta-thalassaemia major. J Karnon D Zeuner J Brown AE Ades B Wonke B Modell, Clin Lab Haematol 1999 21 6 377 385 10.1046/j.1365-2257.1999.00262.x 10671989
9. Cost-benefit analysis of a national thalassaemia prevention programme in Israel. G Ginsberg T Tulchinsky D Filon A Goldfarb L Abramov EA Rachmilevitz, J Med Screen 1998 5 3 120 126 9795870
10. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. S de Silva CA Fisher A Premawardhena SP Lamabadusuriya TE Peto G Perera JM Old JB Clegg NF Olivieri DJ Weatherall, Lancet 2000 355 9206 786 791 10.1016/S0140-6736(99)08246-X 10711926
11. Thalassemia in the outpatient department of the Yangon Children's Hospital in Myanmar: cost analysis of the day-care-room services for thalassemia. H Aung Myo H Khin Ei M Thein Thein, Southeast Asian J Trop Med Public Health 1992 23 2 273 277 1439981
12. Prevention and control program of thalassemia under the Universal Health Coverage Scheme. B Ngarmsiriudom, 8th National Conference on Thalassemial Kkonkaen: Department of Health 2002 14 23
13. Cost and benefits of thalassemia prevention and control program: a case of Faculty of Medicine, Chiangmai University (in Thai language). C Wanapirak, 8th National Conference on Thalassemia Khonkaen: Department of Health 2002 24 31
14. G Kobelt, Health economics: an introduction to economic evaluation London: Office of Health Economics second 2002
15. L Kumaranayake J Pepperall H Goodman A Mills D Walker, Costing guidelines for HIV prevention strategies Geneva: UNAIDS 2000
16. N Cappellini A Cohen A Eleftheriou A Piga J Porter, Guideline for the clinical management of thalassaemia Nicosia: Thalassaemia International Federation 2 2007
17. D Altman, Practical statistics for medical reserarch London: Chapman & Hall 1996
18. J Cohen P Cohen SG West LS Aiken, Applied multiple regression/correlation analysis for the behavioral sciences New Jersey: Lawrence Erlbaum Associates, Inc. Third 2003
19. Foreign Exchange Rates. Bank of Thailand, http://www.bot.or.th/english/ statistics/financialmarkets/exchangerate/-layouts/Application/ExchangeRate/ ExchangeRate.aspx
20. Y Kadkanklai, Situation of health and environment in Thailand (in Thai language) Nonthaburi: Department of Health 1999
21. Keynote address: The challenge of thalassemia for the developing countries. DJ Weatherall, Ann N Y Acad Sci 2005 1054 11 17 10.1196/annals.1345. 002 16339646
22. Biases in cost measurement for economic evaluation studies in health care. P Jacobs J Baladi, Health Economics 1996 5 525 529 10.1002/(SICI)1099- 1050(199611)5:6<525::AID-HEC2333.0.CO;2-E 9003939
23. Impact of thalassemia major on patients and their families. JJ Caro A Ward TC Green K Huybrechts A Arana S Wait A Eleftheriou, Acta Haematol 2002 107 3 150 157 10.1159/000057633 11978936
24. Cost-benefit analysis of a thalassemia disease prevention program. JT Ostrowsky A Lippman CR Scriver, Am J Public Health 1985 75 7 732 736 10.2105/AJPH.75.7.732 3923848
25. Effect of costing methods on unit cost of hospital medical services. A Riewpaiboon S Malaroje S Kongsawatt, Trop Med Int Health 2007 12 4 554 563 17445147
26. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. TE Delea J Edelsberg O Sofrygin SK Thomas JF Baladi PD Phatak TD Coates, Transfusion 2007 47 10 1919 1929 10.1111/j.1537-2995.2007.01416.x 17880620